Worse Survival Observed Among Patients Diagnosed with Cancer During the First 2 Years of the COVID-19 Pandemic By Ogkologos - February 16, 2026 214 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the US cohort study Source RELATED ARTICLESMORE FROM AUTHOR Ovarian Reserve Better Indicator of Adjuvant Chemotherapy Benefit than Self-Reported Menopause Status, Age, or Other Hormone Levels Immune-Modulating SBRT Plus Anti-PD-L1 May Convert Immune-Cold ER-positive, HER2-negative EBC Into More Inflamed Tumours and Improve Response EMA Recommends Extension of Therapeutic Indications for Serplulimab MOST POPULAR Will Ponsegromab Be a Game Changer for Cancer Cachexia? October 17, 2024 At NCI, A Robust and Rapid Response to the COVID-19 Pandemic April 17, 2020 HPV Vaccine May Provide Men with “Herd Immunity” against Oral HPV... October 8, 2019 Reflections May 26, 2021 Load more HOT NEWS Rookie Cop Saves Infant From Choking How the history of medicine influenced our perception of cancer Presence of Tumour and Higher Levels of LAG3-positive T-cells in the... EMA Pharmacovigilance Risk Assessment Committee Advice on Safety-Related Aspects of the...
